Dixon Mitchell Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$375K Hold
408
0.01% 65
2025
Q4
$438K Buy
+408
New +$390K 0.01% 58
2025
Q2
Sell
-9
Closed -$7.43K 91
2025
Q1
$7.43K Hold
9
﹤0.01% 79
2024
Q4
$6.95K Buy
+9
New +$7.45K ﹤0.01% 97
2015
Q3
Sell
-2,400
Closed -$200K 67
2015
Q2
$200K Buy
+2,400
New +$183K 0.03% 66
2014
Q3
Sell
-29,040
Closed -$1.81M 65
2014
Q2
$1.81M Sell
29,040
-3,670
-11% -$219K 0.26% 56
2014
Q1
$1.93M Buy
32,710
+890
+3% +$49.7K 0.3% 55
2013
Q4
$1.62M Buy
31,820
+1,820
+6% +$91.1K 0.26% 56
2013
Q3
$1.51M Sell
30,000
-760
-2% -$39.8K 0.26% 57
2013
Q2
$1.51M Buy
+30,760
New +$1.67M 0.28% 53

Other funds holding LLY

Dixon Mitchell Investment Counsel's LLY Position: Q1 2026 in Review

Dixon Mitchell Investment Counsel held its Eli Lilly (LLY) position steady in Q1 2026 at 408 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #65.

Dixon Mitchell Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.93M in Q1 2014. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Dixon Mitchell Investment Counsel held 408 shares of Eli Lilly worth $375K as of Q1 2026.
  • Dixon Mitchell Investment Counsel left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.01% of Dixon Mitchell Investment Counsel's portfolio in Q1 2026, its #65 holding.
  • Dixon Mitchell Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 10 quarters since.
  • Dixon Mitchell Investment Counsel's Eli Lilly position peaked at $1.93M in Q1 2014.
  • 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Dixon Mitchell Investment Counsel's 13F filing for Q1 2026, filed 14 May 2026.